These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
526 related articles for article (PubMed ID: 15842581)
21. Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease. Yamamoto M; Iwasa M; Iwata K; Kaito M; Sugimoto R; Urawa N; Mifuji R; Konishi M; Kobayashi Y; Adachi Y J Gastroenterol Hepatol; 2007 Apr; 22(4):498-503. PubMed ID: 17376040 [TBL] [Abstract][Full Text] [Related]
22. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634 [TBL] [Abstract][Full Text] [Related]
23. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582 [TBL] [Abstract][Full Text] [Related]
25. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C. Giannini E; Botta F; Cataldi A; Tenconi GL; Ceppa P; Barreca T; Testa R Hepatogastroenterology; 1999; 46(28):2422-5. PubMed ID: 10522010 [TBL] [Abstract][Full Text] [Related]
26. Predictors of fibrosis in Asian patients with non-alcoholic steatohepatitis. Tsang SW; Ng WF; Wu BP; Chow DA; Li ET; Wong TC J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):116-21. PubMed ID: 16706822 [TBL] [Abstract][Full Text] [Related]
27. Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months. Keshishian A; Zahriya K; Willes EB Obes Surg; 2005; 15(10):1418-23. PubMed ID: 16354521 [TBL] [Abstract][Full Text] [Related]
28. Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH). Capristo E; Miele L; Forgione A; Vero V; Farnetti S; Mingrone G; Greco AV; Gasbarrini G; Grieco A Eur Rev Med Pharmacol Sci; 2005; 9(5):265-8. PubMed ID: 16231587 [TBL] [Abstract][Full Text] [Related]
29. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Harrison SA; Torgerson S; Hayashi P; Ward J; Schenker S Am J Gastroenterol; 2003 Nov; 98(11):2485-90. PubMed ID: 14638353 [TBL] [Abstract][Full Text] [Related]
30. Non-alcoholic steatohepatitis in children. Nanda K Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336 [TBL] [Abstract][Full Text] [Related]
31. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels. Wong VW; Wong GL; Tsang SW; Hui AY; Chan AW; Choi PC; Chim AM; Chu S; Chan FK; Sung JJ; Chan HL Aliment Pharmacol Ther; 2009 Feb; 29(4):387-96. PubMed ID: 19035982 [TBL] [Abstract][Full Text] [Related]
32. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis. Ito S; Yukawa T; Uetake S; Yamauchi M Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172 [TBL] [Abstract][Full Text] [Related]
33. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Sorbi D; Boynton J; Lindor KD Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476 [TBL] [Abstract][Full Text] [Related]
35. The pilot study of 3-month course of melatonin treatment of patients with nonalcoholic steatohepatitis: effect on plasma levels of liver enzymes, lipids and melatonin. Gonciarz M; Gonciarz Z; Bielanski W; Mularczyk A; Konturek PC; Brzozowski T; Konturek SJ J Physiol Pharmacol; 2010 Dec; 61(6):705-10. PubMed ID: 21224501 [TBL] [Abstract][Full Text] [Related]
36. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis. Caldwell SH; Hespenheide EE; Redick JA; Iezzoni JC; Battle EH; Sheppard BL Am J Gastroenterol; 2001 Feb; 96(2):519-25. PubMed ID: 11232700 [TBL] [Abstract][Full Text] [Related]
37. A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trial. Nelson A; Torres DM; Morgan AE; Fincke C; Harrison SA J Clin Gastroenterol; 2009; 43(10):990-4. PubMed ID: 19448566 [TBL] [Abstract][Full Text] [Related]
38. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial. Harrison SA; Fecht W; Brunt EM; Neuschwander-Tetri BA Hepatology; 2009 Jan; 49(1):80-6. PubMed ID: 19053049 [TBL] [Abstract][Full Text] [Related]
39. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Harrison SA; Torgerson S; Hayashi PH Am J Gastroenterol; 2003 Sep; 98(9):2042-7. PubMed ID: 14499785 [TBL] [Abstract][Full Text] [Related]
40. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease. Haukeland JW; Konopski Z; Linnestad P; Azimy S; Marit Løberg E; Haaland T; Birkeland K; Bjøro K Scand J Gastroenterol; 2005 Dec; 40(12):1469-77. PubMed ID: 16293559 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]